- Home
- Publications
- Publication Search
- Publication Details
Title
Montelukast and Acute Coronary Syndrome: The Endowed Drug
Authors
Keywords
-
Journal
Pharmaceuticals
Volume 15, Issue 9, Pages 1147
Publisher
MDPI AG
Online
2022-09-15
DOI
10.3390/ph15091147
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Montelukast and neuropsychiatric events – a sequence symmetry analysis
- (2022) Christopher W. Fox et al. JOURNAL OF ASTHMA
- Montelukast, an Antagonist of Cysteinyl Leukotriene Signaling, Impairs Burn Wound Healing
- (2022) Alan V. Nguyen et al. PLASTIC AND RECONSTRUCTIVE SURGERY
- Trimetazidine and COVID-19-induced acute cardiac injury: a missed key
- (2022) Hayder M. Al-kuraishy et al. International Journal of Clinical Pharmacy
- Montelukast ameliorated pemetrexed-induced cytotoxicity in hepatocytes by mitigating endoplasmic reticulum (ER) stress and nucleotide oligomerization domain-like receptor protein 3 (NLRP3) activation
- (2022) Zhengdong Fei et al. Bioengineered
- A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19
- (2022) Gomaa Mostafa-Hedeab et al. INFLAMMOPHARMACOLOGY
- COVID-19 and corticosteroids: a narrative review
- (2022) Gaber El-Saber Batiha et al. INFLAMMOPHARMACOLOGY
- Pentoxifylline and berberine mitigate diclofenac-induced acute nephrotoxicity in male rats via modulation of inflammation and oxidative stress
- (2022) Mohammed Alorabi et al. BIOMEDICINE & PHARMACOTHERAPY
- Ameliorative effect of montelukast against carbon tetrachloride-induced hepatotoxicity: Targeting NLRP3 inflammasome pathway
- (2022) Dalia H. El-Kashef et al. LIFE SCIENCES
- Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals
- (2022) Hayder M. Al-kuraishy et al. INFLAMMOPHARMACOLOGY
- The Potential Role of Growth Differentiation Factor 15 in COVID-19: A Corollary Subjective Effect or Not?
- (2022) Ahmad O. Babalghith et al. Diagnostics
- Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity
- (2021) Hayder M. Al-kuraishy et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cangrelor: Clinical Data, Contemporary Use, and Future Perspectives
- (2021) Leonardo De Luca et al. Journal of the American Heart Association
- Leukotriene C4 synthase is a novel PPARγ target gene, and leukotriene C4 and D4 activate adipogenesis through cysteinyl LT1 receptors in adipocytes
- (2021) Ko Fujimori et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Regulation and signaling of the GPR17 receptor in oligodendroglial cells
- (2020) Davide Lecca et al. GLIA
- P2Y12 Inhibition beyond Thrombosis: Effects on Inflammation
- (2020) Alexandre Mansour et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Activation of metabolite receptor GPR91 promotes platelet aggregation and transcellular biosynthesis of leukotriene C 4
- (2020) Xiao Tang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a Joint Position Paper from the European Society of Cardiology (ESC) Working Group on Thrombosis, in association with the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI)
- (2020) Diana A Gorog et al. European Heart Journal-Cardiovascular Pharmacotherapy
- Omalizumab for Aspirin-Hypersensitivity and Leukotriene Overproduction in Aspirin-Exacerbated Respiratory Disease: A Randomized Trial
- (2020) Hiroaki Hayashi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Leukotriene B 4 receptor 1 exacerbates inflammation following myocardial infarction
- (2020) Yuma Horii et al. FASEB JOURNAL
- The role of the LTB4-BLT1 axis in health and disease
- (2020) Rui He et al. PHARMACOLOGICAL RESEARCH
- Risk of Psychiatric Adverse Events among Montelukast Users
- (2020) Veronica V. Sansing-Foster et al. Journal of Allergy and Clinical Immunology-In Practice
- Glycogen synthase kinase-3β inhibition alleviates activation of the NLRP3 inflammasome in myocardial infarction
- (2020) Shuhui Wang et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Zafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor γ
- (2019) Tamara Göbel et al. Frontiers in Pharmacology
- Montelukast and Neuropsychiatric Events in Children with Asthma: A Nested Case–Control Study
- (2019) S. Dresden Glockler-Lauf et al. JOURNAL OF PEDIATRICS
- Zafirlukast attenuates advanced glycation end-products (AGEs)-induced degradation of articular extracellular matrix (ECM)
- (2019) Changjiang Lei et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Relationship Between C-Reactive Protein to Albumin Ratio and Thrombus Burden in Patients With Acute Coronary Syndrome
- (2019) Hakan Duman et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- The NLRP3 inflammasome in acute myocardial infarction
- (2019) Adolfo Gabriele Mauro et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Early and Sustained Increases in Leukotriene B4 Levels Are Associated with Poor Clinical Outcome in Ischemic Stroke Patients
- (2019) Su Jing Chan et al. Neurotherapeutics
- Potential role of leukotriene receptor antagonists in reducing cardiovascular and cerbrovascular risk: A systematic review of human clinical trials and in vivo animal studies
- (2018) Malvina Hoxha et al. BIOMEDICINE & PHARMACOTHERAPY
- Montelukast inhibits RANKL‑induced osteoclast formation and bone loss via CysLTR1 and P2Y12
- (2018) Ju‑Hee Kang et al. Molecular Medicine Reports
- An Update on Radial Artery Access and Best Practices for Transradial Coronary Angiography and Intervention in Acute Coronary Syndrome: A Scientific Statement From the American Heart Association
- (2018) Peter J. Mason et al. Circulation-Cardiovascular Interventions
- Association between the EPHX2 p.Lys55Arg polymorphism and prognosis following an acute coronary syndrome
- (2018) Akinyemi Oni-Orisan et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Montelukast attenuates rotenone-induced microglial activation/p38 MAPK expression in rats: Possible role of its antioxidant, anti-inflammatory and antiapoptotic effects
- (2018) Riham M. Mansour et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Montelukast enhances cytocidal effects of carfilzomib in multiple myeloma by inhibiting mTOR pathway
- (2018) Jia Tong et al. CANCER BIOLOGY & THERAPY
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field
- (2017) Malvina Hoxha et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Vascular endothelial cells senescence is associated with NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome activation via reactive oxygen species (ROS)/thioredoxin-interacting protein (TXNIP) pathway
- (2017) Yanlin Yin et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Role of the Cysteinyl Leukotrienes in the Pathogenesis and Progression of Cardiovascular Diseases
- (2017) Francesca Colazzo et al. MEDIATORS OF INFLAMMATION
- Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue nevi
- (2016) Inga Möller et al. MODERN PATHOLOGY
- Montelukast attenuates lipopolysaccharide-induced cardiac injury in rats
- (2015) AE Khodir et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- Discovery of Gemilukast (ONO-6950), a Dual CysLT1 and CysLT2 Antagonist As a Therapeutic Agent for Asthma
- (2015) Satoshi Itadani et al. JOURNAL OF MEDICINAL CHEMISTRY
- Montelukast Attenuates Neuropathic Pain Through Inhibiting p38 Mitogen-Activated Protein Kinase and Nuclear Factor-Kappa B in a Rat Model of Chronic Constriction Injury
- (2014) Chenghua Zhou et al. ANESTHESIA AND ANALGESIA
- DanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4
- (2014) Yong Wang et al. BMC Complementary and Alternative Medicine
- Multidrug Resistance Protein 1 (MRP1, ABCC1), a “Multitasking” ATP-binding Cassette (ABC) Transporter
- (2014) Susan P. C. Cole JOURNAL OF BIOLOGICAL CHEMISTRY
- Multiple-Site Activation of the Cysteinyl Leukotriene Receptor 2 Is Required for Exacerbation of Ischemia/Reperfusion Injury
- (2013) Nathan C. Ni et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Montelukast and irbesartan ameliorate metabolic and hepatic disorders in fructose-induced metabolic syndrome in rats
- (2013) Mohamed A. Ibrahim et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Effects of soluble epoxide hydrolase inhibitor on the expression of fatty acid synthase in peripheral blood mononuclear cell in patients with acute coronary syndrome
- (2013) Xuan Zhao et al. Lipids in Health and Disease
- Cysteinyl leukotrienes regulate endothelial cell inflammatory and proliferative signals through CysLT2 and CysLT1 receptors
- (2013) Ernest Duah et al. Scientific Reports
- Cysteinyl leukotriene signaling through perinuclear CysLT1 receptors on vascular smooth muscle cells transduces nuclear calcium signaling and alterations of gene expression
- (2012) Alison Eaton et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Cysteinyl Leukotriene Signaling Aggravates Myocardial Hypoxia in Experimental Atherosclerotic Heart Disease
- (2012) Elena Nobili et al. PLoS One
- Thrombosis and Acute coronary syndrome
- (2012) Rosanna Abbate et al. THROMBOSIS RESEARCH
- Mitogen-activated protein kinases activation in T lymphocytes of patients with acute coronary syndromes
- (2011) Ciro Indolfi et al. BASIC RESEARCH IN CARDIOLOGY
- A Selective Cysteinyl Leukotriene Receptor 2 Antagonist Blocks Myocardial Ischemia/Reperfusion Injury and Vascular Permeability in Mice
- (2011) N. C. Ni et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Atorvastatin Reduces Plaque Vulnerability in an Atherosclerotic Rabbit Model by Altering the 5-Lipoxygenase Pathway
- (2010) Guangyi Zhou et al. CARDIOLOGY
- Soluble Epoxide Hydrolase in Atherosclerosis
- (2010) Yi-Xin Jim Wang et al. Current Atherosclerosis Reports
- Inhibition of leukotriene C4 action reduces oxidative stress and apoptosis in cardiomyocytes and impedes remodeling after myocardial injury
- (2010) Ulrich M. Becher et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Montelukast Inhibits Matrix Metalloproteinases Expression in Atherosclerotic Rabbits
- (2009) Dezhi Liu et al. CARDIOVASCULAR DRUGS AND THERAPY
- Differential inflammatory activity across human abdominal aortic aneurysms reveals neutrophil-derived leukotriene B4 as a major chemotactic factor released from the intraluminal thrombus
- (2009) Xavier Houard et al. FASEB JOURNAL
- Genetics and pharmacogenetics of the leukotriene pathway
- (2009) Kelan G. Tantisira et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases
- (2009) John D. Imig et al. NATURE REVIEWS DRUG DISCOVERY
- Genetic Variation in the Leukotriene Pathway and Carotid Intima-Media Thickness
- (2009) Steve Bevan et al. STROKE
- Endothelial Cysteinyl Leukotriene 2 Receptor Expression Mediates Myocardial Ischemia-Reperfusion Injury
- (2008) Wei Jiang et al. AMERICAN JOURNAL OF PATHOLOGY
- Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo
- (2008) Atsuko Motoki et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Anti-atherogenic effects of montelukast associated with reduced MCP-1 expression in a rabbit carotid balloon injury model
- (2008) Song Ge et al. ATHEROSCLEROSIS
- Leukotriene Signaling in Atherosclerosis and Ischemia
- (2008) Magnus Bäck CARDIOVASCULAR DRUGS AND THERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started